Operating Lease, Right-of-Use Asset of Sonoma Pharmaceuticals, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Sonoma Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $642,000, a 439% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sonoma Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $642,000 +$523,000 +439% 31 Dec 2025 10-Q 10 Feb 2026 2026 Q3
Q3 2025 $479,000 +$317,000 +196% 30 Sep 2025 10-Q 04 Nov 2025 2026 Q2
Q2 2025 $536,000 +$320,000 +148% 30 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 $84,000 -$202,000 -71% 31 Mar 2025 10-Q 10 Feb 2026 2026 Q3
Q4 2024 $119,000 -$222,000 -65% 31 Dec 2024 10-Q 05 Feb 2025 2025 Q3
Q3 2024 $162,000 -$188,000 -54% 30 Sep 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 $216,000 -$138,000 -39% 30 Jun 2024 10-Q 08 Aug 2024 2025 Q1
Q1 2024 $286,000 -$132,000 -32% 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q4 2023 $341,000 -$130,000 -28% 31 Dec 2023 10-Q 08 Feb 2024 2024 Q3
Q3 2023 $350,000 -$180,000 -34% 30 Sep 2023 10-Q 13 Nov 2023 2024 Q2
Q2 2023 $354,000 -$124,000 -26% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 $418,000 -$141,000 -25% 31 Mar 2023 10-K 17 Jun 2024 2024 FY
Q4 2022 $471,000 -$152,000 -24% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 $530,000 -$170,000 -24% 30 Sep 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 $478,000 -$244,000 -34% 30 Jun 2022 10-Q 11 Aug 2022 2023 Q1
Q1 2022 $559,000 -$210,000 -27% 31 Mar 2022 10-K 21 Jun 2023 2023 FY
Q4 2021 $623,000 -$48,000 -7.2% 31 Dec 2021 10-Q 11 Feb 2022 2022 Q3
Q3 2021 $700,000 +$66,000 +10% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 $722,000 +$379,000 +110% 30 Jun 2021 10-Q 16 Aug 2021 2022 Q1
Q1 2021 $769,000 +$410,000 +114% 31 Mar 2021 10-K 13 Jul 2022 2022 FY
Q4 2020 $671,000 -$386,000 -37% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 $634,000 -$544,000 -46% 30 Sep 2020 10-Q 20 Nov 2020 2021 Q2
Q2 2020 $343,000 -$973,000 -74% 30 Jun 2020 10-Q/A 17 Nov 2020 2021 Q1
Q1 2020 $359,000 +$359,000 31 Mar 2020 10-K 14 Jul 2021 2021 FY
Q4 2019 $1,057,000 31 Dec 2019 10-Q 14 Feb 2020 2020 Q3
Q3 2019 $1,178,000 30 Sep 2019 10-Q 14 Nov 2019 2020 Q2
Q2 2019 $1,316,000 30 Jun 2019 10-Q 13 Aug 2019 2020 Q1
Q1 2019 $0 31 Mar 2019 10-K 10 Jul 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.